1Arroyo V,Gines P,Gerbes AL,et al.Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in crirrhosis[J].Hepatology,1996,23(1):164-176.
2Duvoux C,Zanditenas D,Hezode C,et al.Effect of noradrenal and albumin in patients with type hepatrorenal syndrome:a pilot study[J].Hepatology,2002,36 (2):374-378.
5Soper CP,Latif AB,Bending MR.Amelioration of hepatorenal syndrome with select-tive endothelin-A antagonist[J],Lancet 1996,347(9018):1842-1843.
6Moreau R,Durand F,Polynard T,et al.Terlipressin in patients with cirrhosis and type I hepatorenal syndrome:a retrospective multicenter study[J].Gastroenterology,2002,122(7):920-930.
7Solanki P,Chawla A,Garg R,et al.Beneficial effects of terlipressin in hepaorenal,syndrom:a prospective,randomized placebo-controlled clinical trial[J].J Gastroenterol Hepato,2003,18(2):152-156.
9Guevara M,Gines P,Fernandez-Esparrach G,et al.Reversibility of hepatorenal syndrome by prolonged administration of orni-pressin and plasma volume expansion[J].Hepatology,1998,27(1):35-41.
10Gulberg V,Bilzer M,Gerbes AL,Long-term therapy and reteratment of hepatorenal syndrome type I with ornipressin and dopamine[J].Hepatology,1999,30(4):870-875.
二级参考文献44
1John Slavin,Paula Ghaneh,Robert Sutton,Mark Hartley,Peter Rowlands,Conall Garvey,Mark Hughes,John Neoptolemos.Management of necrotizing pancreatitis[J].World Journal of Gastroenterology,2001,7(4):476-481. 被引量：21
7Arroyo V,Gines P,Gerbes AL,et al.Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in crirrhosis[J].Hepatology,1996,23(1):164-176.
8Duvoux C,Zanditenas D,Hezode C,et al.Effect of noradrenal and albumin in patients with type Ⅰ hepatrorenal syndrome:a pilot study[J].Hepatology,2002,36(2):374-378.
9Wong F,Blendis L.New challenge of hepatorenal syndrome:prevention and treatment[J].Hepatology,2001,34(6):1242-1251.
